Jiabo Di

768 total citations
39 papers, 578 citations indexed

About

Jiabo Di is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jiabo Di has authored 39 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in Jiabo Di's work include Cancer Genomics and Diagnostics (10 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal Cancer Treatments and Studies (7 papers). Jiabo Di is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal Cancer Treatments and Studies (7 papers). Jiabo Di collaborates with scholars based in China, Ethiopia and Netherlands. Jiabo Di's co-authors include Zaozao Wang, Beihai Jiang, Xiangqian Su, Pin Gao, Hong Yang, Tjitske Duiveman‐de Boer, Ruurd Torensma, Carl G. Figdor, Jie Yang and Jiadi Xing and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Jiabo Di

37 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiabo Di China 15 286 237 168 132 70 39 578
Qingfeng Ni China 15 334 1.2× 113 0.5× 256 1.5× 88 0.7× 98 1.4× 32 586
Taro Tobo Japan 17 434 1.5× 169 0.7× 280 1.7× 175 1.3× 101 1.4× 34 747
Rosemary Jeffery United Kingdom 14 326 1.1× 214 0.9× 211 1.3× 95 0.7× 89 1.3× 18 715
Nina Korzeniewski Germany 15 425 1.5× 175 0.7× 159 0.9× 117 0.9× 39 0.6× 23 679
Gian Luca Rampioni Vinciguerra Italy 12 238 0.8× 181 0.8× 107 0.6× 134 1.0× 29 0.4× 26 452
Mirte Mayke Streppel Netherlands 9 312 1.1× 255 1.1× 159 0.9× 101 0.8× 76 1.1× 11 578
Zhengchuan Niu China 16 382 1.3× 240 1.0× 278 1.7× 72 0.5× 99 1.4× 29 698
James Elliott United Kingdom 11 187 0.7× 169 0.7× 64 0.4× 194 1.5× 67 1.0× 33 503
José M. del Casar Spain 14 200 0.7× 387 1.6× 333 2.0× 114 0.9× 254 3.6× 25 756
Jean Marie Bruey United States 6 214 0.7× 177 0.7× 91 0.5× 162 1.2× 154 2.2× 8 507

Countries citing papers authored by Jiabo Di

Since Specialization
Citations

This map shows the geographic impact of Jiabo Di's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiabo Di with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiabo Di more than expected).

Fields of papers citing papers by Jiabo Di

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiabo Di. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiabo Di. The network helps show where Jiabo Di may publish in the future.

Co-authorship network of co-authors of Jiabo Di

This figure shows the co-authorship network connecting the top 25 collaborators of Jiabo Di. A scholar is included among the top collaborators of Jiabo Di based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiabo Di. Jiabo Di is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xinying, Yan Ran, Hong Yang, et al.. (2025). MTCH2 Deficiency Promotes E2F4/TFRC‐Mediated Ferroptosis and Sensitizes Colorectal Cancer Liver Metastasis to Sorafenib. Advanced Science. 12(36). e00019–e00019.
2.
Yang, Xinying, Yan Ran, Hong Yang, et al.. (2025). WFDC3 sensitizes colorectal cancer to chemotherapy by regulating ATM / ATR kinase signaling pathway. The FASEB Journal. 39(2). e70329–e70329. 1 indexed citations
3.
Zhao, Min, Zaozao Wang, Jiabo Di, et al.. (2023). WFDC3 inhibits tumor metastasis by promoting the ERβ-mediated transcriptional repression of TGFBR1 in colorectal cancer. Cell Death and Disease. 14(7). 425–425. 11 indexed citations
4.
Zhao, Min, Zaozao Wang, Jiabo Di, et al.. (2022). A stop-gain mutation in GXYLT1 promotes metastasis of colorectal cancer via the MAPK pathway. Cell Death and Disease. 13(4). 395–395. 8 indexed citations
7.
Wang, Zaozao, Bin Kang, Qianqian Gao, et al.. (2021). Quadruple‐editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS‐mutated colorectal cancer cells. Cancer Science. 112(9). 3895–3910. 8 indexed citations
8.
Liu, Yining, Lei Chen, Tianqi Liu, et al.. (2021). Genome-wide circular RNA (circRNA) and mRNA profiling identify a circMET-miR-410-3p regulatory motif for cell growth in colorectal cancer. Genomics. 114(1). 351–360. 12 indexed citations
9.
Wu, Fan, Pin Gao, Wei Wu, et al.. (2018). STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 144–144. 29 indexed citations
10.
Liu, Mingshan, Yang Liu, Jiabo Di, et al.. (2017). Multi-region and single-cell sequencing reveal variable genomic heterogeneity in rectal cancer. BMC Cancer. 17(1). 787–787. 30 indexed citations
11.
Wu, Wei, Fan Wu, Zaozao Wang, et al.. (2017). CENPH Inhibits Rapamycin Sensitivity by Regulating GOLPH3-dependent mTOR Signaling Pathway in Colorectal Cancer. Journal of Cancer. 8(12). 2163–2172. 20 indexed citations
12.
Jiang, Beihai, Aidong Wang, Jiabo Di, et al.. (2015). GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer. PLoS ONE. 10(8). e0136020–e0136020. 9 indexed citations
13.
Cui, Ming, Ziyu Li, Jiadi Xing, et al.. (2015). A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer. Medical Oncology. 32(10). 241–241. 42 indexed citations
14.
Liu, Maoxing, Hong Qu, Zhaode Bu, et al.. (2015). Validation of the Memorial Sloan-Kettering Cancer Center Nomogram to Predict Overall Survival After Curative Colectomy in a Chinese Colon Cancer Population. Annals of Surgical Oncology. 22(12). 3881–3887. 15 indexed citations
15.
Cui, Ming, Beihai Jiang, Zhendan Yao, et al.. (2015). Evaluation of immune responses of gastric cancer patients treated by laparoscopic and open gastrectomy. Medical Oncology. 32(11). 253–253. 12 indexed citations
16.
Wang, Zaozao, Beihai Jiang, Jiabo Di, et al.. (2014). GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy. Journal of Translational Medicine. 12(1). 15–15. 30 indexed citations
17.
Di, Jiabo. (2013). Aiming to immune elimination of ovarian cancer stem cells. World Journal of Stem Cells. 5(4). 149–149. 6 indexed citations
18.
Di, Jiabo, Tjitske Duiveman‐de Boer, Petra L.M. Zusterzeel, et al.. (2013). The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients. Cellular Oncology. 36(5). 363–374. 55 indexed citations
19.
Di, Jiabo, Leon F.A.G. Massuger, Tjitske Duiveman‐de Boer, et al.. (2013). Functional OCT4-specific CD4+and CD8+T cells in healthy controls and ovarian cancer patients. OncoImmunology. 2(5). e24271–e24271. 12 indexed citations
20.
Di, Jiabo, Tjitske Duiveman‐de Boer, Carl G. Figdor, & Ruurd Torensma. (2011). Eradicating cancer cells: struggle with a chameleon. Oncotarget. 2(1-2). 99–101. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026